No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs193080743 |
chr14:105331238-105331239 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs539678781 |
chr14:105331257-105331258 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs543143331 |
chr14:105331292-105331293 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs373070078 |
chr14:105331296-105331297 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs556371721 |
chr14:105331300-105331301 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs200210525 |
chr14:105331303-105331304 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs546341589 |
chr14:105331338-105331339 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive regionlncRNA
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs576225070 |
chr14:105331447-105331448 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
20 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs8008126 |
chr14:105331457-105331458 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
20 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs2841221 |
chr14:105331466-105331467 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
20 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs2841222 |
chr14:105331483-105331484 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs571958317 |
chr14:105331487-105331488 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs540664791 |
chr14:105331488-105331489 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs185665842 |
chr14:105331497-105331498 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs548529289 |
chr14:105331728-105331729 |
Bivalent/Poised TSS Active TSS Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs560879514 |
chr14:105331823-105331824 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs2582564 |
chr14:105331835-105331836 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs112614583 |
chr14:105331845-105331846 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs2582563 |
chr14:105331893-105331894 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs562710870 |
chr14:105331964-105331965 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs72635202 |
chr14:105332001-105332002 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs548231422 |
chr14:105332041-105332042 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs568459265 |
chr14:105332056-105332057 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs112110462 |
chr14:105332091-105332092 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs527726822 |
chr14:105332128-105332129 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs547459146 |
chr14:105332139-105332140 |
Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|